Wasatch Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $337M | Sell |
636,595
-137,336
| -18% | -$63.4M | 2.21% | 5 |
|
|
2026
Q1 | $372M | Buy |
773,931
+125,625
| +19% | +$64.3M | 2.47% | 4 |
|
|
2025
Q4 | $364M | Sell |
648,306
-277,657
| -30% | -$158M | 2.16% | 8 |
|
|
2025
Q3 | $476M | Sell |
925,963
-19,851
| -2% | -$8.67M | 2.56% | 7 |
|
|
2025
Q2 | $297M | Buy |
945,814
+116,354
| +14% | +$34.9M | 1.55% | 16 |
|
|
2025
Q1 | $253M | Sell |
829,460
-107,382
| -11% | -$36.1M | 1.41% | 18 |
|
|
2024
Q4 | $311M | Buy |
936,842
+28,161
| +3% | +$9.55M | 1.54% | 15 |
|
|
2024
Q3 | $303M | Sell |
908,681
-58,602
| -6% | -$22.3M | 1.49% | 16 |
|
|
2024
Q2 | $398M | Sell |
967,283
-7,132
| -0.7% | -$2.82M | 2.13% | 7 |
|
|
2024
Q1 | $394M | Sell |
974,415
-211,766
| -18% | -$74.5M | 2.06% | 7 |
|
|
2023
Q4 | $364M | Sell |
1,186,181
-85,655
| -7% | -$23.1M | 2% | 8 |
|
|
2023
Q3 | $308M | Sell |
1,271,836
-297,065
| -19% | -$76M | 1.95% | 8 |
|
|
2023
Q2 | $377M | Sell |
1,568,901
-289,753
| -16% | -$60.2M | 2.28% | 5 |
|
|
2023
Q1 | $350M | Buy |
1,858,654
+220,836
| +13% | +$45.7M | 2.18% | 7 |
|
|
2022
Q4 | $348M | Sell |
1,637,818
-517,688
| -24% | -$103M | 2.34% | 5 |
|
|
2022
Q3 | $339M | Sell |
2,155,506
-217,717
| -9% | -$34.7M | 2.35% | 7 |
|
|
2022
Q2 | $355M | Sell |
2,373,223
-355,169
| -13% | -$51.4M | 2.25% | 6 |
|
|
2022
Q1 | $446M | Buy |
2,728,392
+294,103
| +12% | +$48.5M | 2.2% | 6 |
|
|
2021
Q4 | $530M | Sell |
2,434,289
-61,773
| -2% | -$12.9M | 2.16% | 3 |
|
|
2021
Q3 | $472M | Buy |
2,496,062
+46,770
| +2% | +$8.53M | 1.92% | 6 |
|
|
2021
Q2 | $433M | Sell |
2,449,292
-204,694
| -8% | -$35.3M | 1.76% | 8 |
|
|
2021
Q1 | $435M | Sell |
2,653,986
-187,008
| -7% | -$28.6M | 1.96% | 4 |
|
|
2020
Q4 | $395M | Buy |
2,840,994
+570,266
| +25% | +$71.9M | 1.95% | 7 |
|
|
2020
Q3 | $254M | Sell |
2,270,728
-290,275
| -11% | -$33.6M | 1.61% | 12 |
|
|
2020
Q2 | $238M | Buy |
2,561,003
+270,621
| +12% | +$23M | 1.72% | 13 |
|
|
2020
Q1 | $168M | Buy |
2,290,382
+485,397
| +27% | +$42.1M | 1.75% | 15 |
|
|
2019
Q4 | $152M | Buy |
1,804,985
+398,775
| +28% | +$30.9M | 1.24% | 26 |
|
|
2019
Q3 | $118M | Sell |
1,406,210
-598,917
| -30% | -$45.3M | 1.13% | 31 |
|
|
2019
Q2 | $131M | Buy |
2,005,127
+600,686
| +43% | +$34.6M | 1.28% | 23 |
|
|
2019
Q1 | $82.8M | Buy |
1,404,441
+209,449
| +18% | +$12.5M | 0.9% | 45 |
|
|
2018
Q4 | $63.3M | Buy |
+1,194,992
| New | +$65.6M | 0.84% | 43 |
|
Other funds holding MEDP
Wasatch Advisors's MEDP Position: Q2 2026 in Review
Wasatch Advisors reduced its Medpace (MEDP) stake by 18% in Q2 2026, selling an estimated $63.4M and leaving 636,595 shares worth $337M. The position accounts for 2.21% of the portfolio, ranked #5.
Wasatch Advisors first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $530M in Q4 2021. 696 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Wasatch Advisors held 636,595 shares of Medpace worth $337M as of Q2 2026.
- Wasatch Advisors sold 137,336 Medpace shares in Q2 2026, an estimated $63.4M.
- Medpace made up 2.21% of Wasatch Advisors's portfolio in Q2 2026, its #5 holding.
- Wasatch Advisors first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- Wasatch Advisors's Medpace position peaked at $530M in Q4 2021.
- 696 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.